Response to ‘Comment on ‘Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy’’ – (Eye 31, 346 (February 2017))
9 February 2017
This news item is available to RCOphth members only, please log in below to access.